140 related articles for article (PubMed ID: 8505641)
21. [The MR tomographic findings in cranial manifestations of neurofibromatosis].
Vestring T; Fahrendorf G; Bongartz G; Reuther G; Peters PE
Rofo; 1990 Dec; 153(6):678-82. PubMed ID: 2176321
[TBL] [Abstract][Full Text] [Related]
22. T2-weighted hyperintensities (unidentified bright objects) in children with neurofibromatosis 1: their impact on cognitive function.
Goh WH; Khong PL; Leung CS; Wong VC
J Child Neurol; 2004 Nov; 19(11):853-8. PubMed ID: 15658789
[TBL] [Abstract][Full Text] [Related]
23. Non-neoplastic brain abnormalities on MRI in children and adolescents with neurofibromatosis type 1.
Raininko R; Thelin L; Eeg-Olofsson O
Neuropediatrics; 2001 Oct; 32(5):225-30. PubMed ID: 11748492
[TBL] [Abstract][Full Text] [Related]
24. Special issues in the management of gliomas in children with neurofibromatosis 1.
Pollack IF; Mulvihill JJ
J Neurooncol; 1996; 28(2-3):257-68. PubMed ID: 8832467
[TBL] [Abstract][Full Text] [Related]
25. Unidentified bright objects in neurofibromatosis type 1: conventional MRI in the follow-up and correlation of microstructural lesions on diffusion tensor images.
Ferraz-Filho JR; José da Rocha A; Muniz MP; Souza AS; Goloni-Bertollo EM; Pavarino-Bertelli EC
Eur J Paediatr Neurol; 2012 Jan; 16(1):42-7. PubMed ID: 22088602
[TBL] [Abstract][Full Text] [Related]
26. Neurofibromatosis type 1: magnetic resonance imaging findings.
DiMario FJ; Ramsby G; Greenstein R; Langshur S; Dunham B
J Child Neurol; 1993 Jan; 8(1):32-9. PubMed ID: 8445170
[TBL] [Abstract][Full Text] [Related]
27. Neurofibromatosis type 1: the evolution of deep gray and white matter MR abnormalities.
Itoh T; Magnaldi S; White RM; Denckla MB; Hofman K; Naidu S; Bryan RN
AJNR Am J Neuroradiol; 1994 Sep; 15(8):1513-9. PubMed ID: 7985572
[TBL] [Abstract][Full Text] [Related]
28. CT detection of basal ganglion lesions in neurofibromatosis type 1: correlation with MRI.
Menor F; Marti-Bonmatí L
Neuroradiology; 1992; 34(4):305-7. PubMed ID: 1528439
[TBL] [Abstract][Full Text] [Related]
29. [Spontaneous regression of basal ganglia lesions in a case of neurofibromatosis type 1 (case report)].
Oztürk M; Ozyazgan I; Mavili E; Orhan S
Tani Girisim Radyol; 2003 Dec; 9(4):439-42. PubMed ID: 14730952
[TBL] [Abstract][Full Text] [Related]
30. Brainstem lesions in neurofibromatosis type 1.
Ullrich NJ; Raja AI; Irons MB; Kieran MW; Goumnerova L
Neurosurgery; 2007 Oct; 61(4):762-6; discussion 766-7. PubMed ID: 17986937
[TBL] [Abstract][Full Text] [Related]
31. Cranial MR imaging in neurofibromatosis.
Bognanno JR; Edwards MK; Lee TA; Dunn DW; Roos KL; Klatte EC
AJR Am J Roentgenol; 1988 Aug; 151(2):381-8. PubMed ID: 3134807
[TBL] [Abstract][Full Text] [Related]
32. Neurological complications involving the central nervous system in neurofibromatosis type 1.
Hsieh HY; Wu T; Wang CJ; Chin SC; Chen YR
Acta Neurol Taiwan; 2007 Jun; 16(2):68-73. PubMed ID: 17685129
[TBL] [Abstract][Full Text] [Related]
33. Neurofibromatosis in childhood: a review of 25 cases.
Pollnitz R
Med J Aust; 1976 Jul; 2(2):49-52. PubMed ID: 824536
[TBL] [Abstract][Full Text] [Related]
34. Magnetic resonance imaging lesion analysis in neurofibromatosis type 1.
DiMario FJ; Ramsby G
Arch Neurol; 1998 Apr; 55(4):500-5. PubMed ID: 9561977
[TBL] [Abstract][Full Text] [Related]
35. Regression of gadolinium-enhanced lesions in patients affected by neurofibromatosis type 1.
Lucchetta M; Manara R; Perilongo G; Clementi M; Trevisson E
Radiol Med; 2016 Mar; 121(3):214-7. PubMed ID: 26445946
[TBL] [Abstract][Full Text] [Related]
36. Clinical sensitivity and specificity of multiple T2-hyperintensities on brain magnetic resonance imaging in diagnosis of neurofibromatosis type 1 in children: diagnostic accuracy study.
Sabol Z; Resić B; Gjergja Juraski R; Sabol F; Kovac Sizgorić M; Orsolić K; Ozretić D; Sepić-Grahovac D
Croat Med J; 2011 Aug; 52(4):488-96. PubMed ID: 21853543
[TBL] [Abstract][Full Text] [Related]
37. Epilepsy in neurofibromatosis 1.
Vivarelli R; Grosso S; Calabrese F; Farnetani M; Di Bartolo R; Morgese G; Balestri P
J Child Neurol; 2003 May; 18(5):338-42. PubMed ID: 12822818
[TBL] [Abstract][Full Text] [Related]
38. Neurological manifestations of neurofibromatosis type 1: our experience.
Sánchez Marco SB; López Pisón J; Calvo Escribano C; González Viejo I; Miramar Gallart MD; Samper Villagrasa P
Neurologia (Engl Ed); 2022 Jun; 37(5):325-333. PubMed ID: 35672119
[TBL] [Abstract][Full Text] [Related]
39. The association between hypotonia and brain tumors in children with neurofibromatosis type 1.
Wessel LE; Albers AC; Gutmann DH; Dunn CM
J Child Neurol; 2013 Dec; 28(12):1664-7. PubMed ID: 23071069
[TBL] [Abstract][Full Text] [Related]
40. Relationship of cognitive functioning, whole brain volumes, and T2-weighted hyperintensities in neurofibromatosis-1.
Cutting LE; Koth CW; Burnette CP; Abrams MT; Kaufmann WE; Denckla MB
J Child Neurol; 2000 Mar; 15(3):157-60. PubMed ID: 10757470
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
